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Hibiscus sabdariffa L. (Hs, roselle; Malvaceae) has been used traditionally as a food, in herbal drinks, in hot
and cold beverages, as a ﬂavouring agent in the food industry and as a herbal medicine. In vitro and in vivo
studies as well as some clinical trials provide some evidence mostly for phytochemically poorly
characterised Hs extracts. Extracts showed antibacterial, anti-oxidant, nephro- and hepato-protective,
renal/diuretic effect, effects on lipid metabolism (anti-cholesterol), anti-diabetic and anti-hypertensive
effects among others. This might be linked to strong antioxidant activities, inhibition of a-glucosidase
and a-amylase, inhibition of angiotensin-converting enzymes (ACE), and direct vaso-relaxant effect or
calcium channel modulation. Phenolic acids (esp. protocatechuic acid), organic acid (hydroxycitric acid
and hibiscus acid) and anthocyanins (delphinidin-3-sambubioside and cyanidin-3-sambubioside) are
likely to contribute to the reported effects.
More well designed controlled clinical trials are needed which use phytochemically characterised
preparations. Hs has an excellent safety and tolerability record.
 2014 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
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Hibiscus sabdariffa L. (Hs), also known as roselle, is an ideal crop
for developing countries as it is relatively easy to grow, can be
grown as part of multi-cropping systems and can be used as food
and ﬁbre. In China the seeds are used for their oil and the plant
is used for its medicinal properties, while in West Africa the leaves
and powdered seeds are used in meals. Additionally, it is used in
the pharmaceutical and food industries.
A limited number of reviews on Hs have been conducted. Only
one detailed review on the phytochemical, pharmacological and
toxicological properties of Hs (Ali, Al Wabel, & Blunden, 2005)
and two more focused, later reviews are available: One on the
effectiveness of Hs in the treatment of hypertension (Wahabi,
Alansary, Al-Sabban, & Glasziuo, 2010) and another on the
treatment of hypertension and hyperlipidemia (Hopkins, Lamm,
Funk, & Ritenbaugh, 2013). This review will focus not only on the
phytochemistry and pharmacological properties of Hs in more
detail, but also on economic-botanical aspects of Hs, its scientiﬁc
applications and translational research.
2. Botanical description
The genus Hibiscus (Malvaceae) includes more than 300 species
of annual or perennial herbs, shrubs or trees (Wang, Morris, Tonnis,
Davis, & Pederson, 2012). Hs (syn.: Abelmoschus cruentus (Bertol.)
Walp., Furcaria sabdariffa Ulbr., Hibiscus cruentus Bertol., Hibiscus
fraternus L., Hibiscus palmatilobus Baill. and Sabdariffa rubra Kostel
(The Plant list, 2010) is commonly known as roselle, hibiscus,
Jamaica sorrel or red sorrel (English) and in Arabic, karkadeh (Ali
et al., 2005; Ross, 2003). Its native distribution is uncertain, some
believe that is from India or Saudi Arabia (Ismail, Ikram, & Nazri,2008), while Murdock (Murdock, 1959) showed evidence that Hs
was domesticated by the black populations of western Sudan
(Africa) sometime before 4000 BC. Nowadays, it is widely
cultivated in both tropical and subtropical regions (Morton,
1987; USDA, 2007) including India, Saudi Arabia, China, Malaysia,
Indonesia, The Philippines, Vietnam, Sudan, Egypt, Nigeria and
México (Chewonarin et al., 1999; Dung et al., 1999; Eslaminejad
& Zakaria, 2011; Ismail, Ikram, & Nazri, 2008; Mahran,
El-Hossary, & El-Labban, 1979; Rao, 1996; Sharaf, 1962; Yagoub
Ael, Mohamed, Ahmed, & El Tinay, 2004).
There are two main varieties of Hs, the ﬁrst being Hs var.
altissima Wester, cultivated for its jute-like ﬁbre and the second
is Hs var. sabdariffa. The second variety includes shorter bushy
forms, which have been described as races: bhagalpuriensi, interme-
dius, albus and ruber. The ﬁrst variety has green, red-streaked, ined-
ible calyces, while the second and third race have yellow-green
edible calyces (var. ruber) and also yield ﬁbre (Morton, 1987).
2.1. Morphology
Hs var. sabdariffa ruber is an annual, erect, bushy, herbaceous
subshrub that can grow up to 8 ft (2.4 m) tall, with smooth or nearly
smooth, cylindrical, typically red stems. The leaves are alternate, 3
to 5 in (7.5–12.5 cm) long, green with reddish veins and long or
short petioles. The leaves of young seedlings and upper leaves of
older plants are simple; lower leaves are deeply 3 to 5 or even 7
lobed; the margins are toothed. Flowers, borne singly in the leaf
axils, are up to 5 in (12.5 cm)wide, yellowor buffwith a rose ormar-
oon eye, and turn pink as they wither at the end of the day. At this
time, the typically red calyx, consisting of 5 large sepalswith a collar
(epicalyx) of 8 to 12 slim, pointed bracts (or bracteoles) around the
base, begins to enlarge, becomes ﬂeshy, crisp but juicy, 1 1/4 to 2 1/4
426 I. Da-Costa-Rocha et al. / Food Chemistry 165 (2014) 424–443in (3.2–5.7 cm) long and fully encloses the velvety capsule, 1/2 to 3/
4 in (1.25–2 cm) long, which is green when immature, 5-valved,
with each valve containing 3 to 4 kidney-shaped, light-brown seeds,
1/8 to 3/16 in (3–5 mm) long and minutely downy. The capsule
turns brown and splits openwhenmature and dry. The calyx, stems
and leaves are acid and closely resemble the cranberry (Vaccinium
spp.) in ﬂavour (Morton, 1987; Ross, 2003).
2.2. Ecology/cultivation
Hs is easy to grow in most well drained soils but can tolerate
poor soils. It requires 4-8 months growth with night-time temper-
atures with a minimum of 20 C, as well as 13 h of sunlight and a
monthly rainfall ranging from 5–1000 (130–250 mm) during the
ﬁrst few months to prevent premature ﬂowering. Rain or high
humidity during the harvest time and drying process can down-
grade the quality of the calyces and reduce the yield. The quality
of Hs is determined by seed stock, local growing conditions, time
of harvest, post-harvest handling and mainly the drying step. Most
of the time it grows as a supplement crop and it is susceptible to
fungi, viral and bacterial attack and also to insects. A single plant
produces about 1.5 kg of fruit, approximately 8 t/ha. Yields of
leaves may be about 10 t/ha (EcoCrop., 2007; Plotto, 2004).
2.3. Karyotype
2n = 36 (Huang, Zhao, Chen, Chen, & Huang, 1989; Menzel &
Wilson, 1961) and 72 (Chennaveeraiah & Subbarao, 1965; Rao,
1935; Wilson & Menzel, 1964) were observed. Somatic tissue
showing diploid and tetraploid segments were also occasionally
noticed (Tjio, 1948). In a karyomorphological study conducted in
India, both root and ﬂower segments showed great similarity in
the types of chromosomes in the complement. This indicates that
the tetraploid tissue must have arisen in an autotetraploid manner
(Bhatt & Dasgupta, 1976). Later, this species was reported to be tet-
raploid (2n = 72) (Hiron, Alam, Ahmed, Begum, & Alam, 2006).3. Uses – economic botany
3.1. Traditional culinary use
Fresh or dried calyces of H. sabdariffa (cHs) are used in the prep-
aration of herbal drinks, hot and cold beverages, fermented drinks,
wine, jam, jellied confectionaries, ice cream, chocolates, ﬂavouring
agents, puddings and cakes (Bako, Mabrouk, & Abubakar, 2009;
Bolade, Oluwalana, & Ojo, 2009; Esselen & Sammy, 1975; Ismail,
Ikram, & Nazri, 2008; Okoro, 2007; Plotto, 2004; Rao, 1996; Tsai,
McIntosh, Pearce, Camden, & Jordan, 2002; Wilson & Menzel,
1964). In Egypt, the ﬂeshy calyces are used in making ‘‘cacody
tea’’ and fermented drinks (Kochhar, 1986), while in Sudan and
Nigeria, the calyces are boiled with sugar to produce a drink known
as ‘‘Karkade’’ or ‘‘Zoborodo’’ (Gibbon & Pain, 1985). In Mexico this
drink is called Jamaica or ‘‘agua de Jamaica’’’ or ‘‘té de Jamaica’’. In
the West Indies the calyces can also be used as colouring and ﬂa-
vouring ingredient in rum (Ismail, Ikram, & Nazri, 2008).
The seeds are eaten roasted or ground in meals, while the leaves
and shoots are eaten raw or cooked, or as a sour-ﬂavoured vegeta-
ble or condiment (Wilson & Menzel, 1964). In Sudan, the leaves are
eaten green or dried, cooked with onions and groundnuts, while in
Malaysia the cooked leaves are eaten as vegetables (Ismail, Ikram,
& Nazri, 2008). In Africa, the seeds are roasted or ground into pow-
der and used in meals, suh as oily soups and sauces. In China and
West Africa, the seeds are also used for their oil (Atta &
Imaizumi, 2002). Another use for the seed is as a substitute for cof-
fee (Morton, 1987).3.2. Use in local and traditional food and medicine
Hs has been widely used in local medicines. In India, Africa and
Mexico, infusions of the leaves or calyces are traditionally used for
their diuretic, cholerectic, febrifugal and hypotensive effects,
decreasing the viscosity of the blood and stimulating intestinal
peristalsis. It is also recommended as a hypotensive in Senegal
(Morton, 1987). In Egypt, preparations from the calyces have been
used to treat cardiac and nerve diseases and also to increase the
production of urine (diuresis). In Egypt and Sudan, an infusion of
‘‘Karkade’’ calyces is also used to help lower body temperature
(Leung, 1996). In Guatemala it is used for treating drunkenness
(Morton, 1987). In North Africa, calyces preparations are used to
treat sore throats and coughs, as well as genital problems, while
the emollient leaf pulp is used for treating external wounds and
abscesses (Neuwinger, 2000). In India, a decoction from the seeds
is used to relieve pain in urination and indigestion. In Brazil, the
roots are believed to have stomachic and emollient properties.
In Chinese folk medicine, it is used to treat liver disorders and
high blood pressure (Morton, 1987). In Iran, sour hibiscus tea is
reportedly a traditional treatment for hypertension (Burnham,
Wickersham, & Novak, 2002), while in Nigeria the decoction of
the seeds is traditionally used to enhance or induce lactation in
cases of poor milk production, poor letdown and maternal mortal-
ity (Gaya, Mohammad, Suleiman, Maje, & Adekunle, 2009).4. Other uses
4.1. Source of ﬁbre
Hs is one of the most important species grown commercially as
a ﬁbre plant and became increasingly important in India after inde-
pendence and partition with Pakistan, where the most important
jute (Corchorus capsularis L. or Corchorus olitorius L.) growing areas
are. It is used as a jute substitute in making clothing, linen, ﬁshing
nets, ropes and similar items (Clydesdale, Main, & Francis, 1979).
Despite the fact that this species is slow growing, as it requires
about 180 days to produce a satisfactory yield of ﬁbre, there is still
interest in the plant as some varieties of Hs (not edible but ﬁbre
type) have a high degree of genetic resistance to root-knot nema-
todes. The main disadvantages of growing Hs in comparison with
other Hibiscus species is:
(1) The slow growth rate which increases costs in weed control
and land occupation by the crop.
(2) The difﬁculty of separating the ribboning stalks from the
bark when compared to, for example, H. cannabinus
(Wilson & Menzel, 1964).
While the world’s production of Kenaf ﬁbres (H. cannabinus) has
reached 272,000 tons in 2008, Hs ﬁbres have not gained the same
economic importance (http://www.naturalﬁbersinfo.org/natural-
ﬁbers/kenaf/, accessed 09/11/13).
However, Hs ﬁbres are subject to ongoing research showing
promising technical properties when used as a substitute for syn-
thetic or mineral ﬁbres in composite materials, as well as a source
material for high quality paper production (Dutt, Upadhyaya, &
Tyagi, 2010; Kumar, Dutt, & Bharti, 2013; Singha & Kumar, 2008).4.2. Animal feed
The leaves are used for animal fodder and ﬁbre (Plotto, 2004).
The seeds can be used to feed poultry as well as sheep and the res-
idue from the seeds oil extraction can also be used to feed cattle
and chicks (Al-Wandawi, Al-Shaikhly, & Abdul-Rahman, 1984;
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1987; Mukhtar, 2007).
4.3. Cosmetic
In Malaysia the oil is used to produce scrubs and soaps (Ismail,
Ikram, & Nazri, 2008).
4.4. The current importance of H. sabdariffa
Besides its importance as a food or traditional medicine in the
countries of its geographic origin, hibiscus ﬂower is traded and
used worldwide today as an important ingredient in industrially
produced teas and beverages. The United States and Germany are
the primary markets for dried cHs. England satisﬁes most of its
consumers demands by importing herbal teas form Germany
(Plotto, 2004). Statistics for the volume and value of dried hibiscus
imported into these markets were not available, but the major cli-
ents for hibiscus importers are herbal teas manufactures, as this
plant is used as base in many herbal/fruit teas, along with apple
peel, orange peel and lemon twist. (McCaleb, 2000; Plotto, 2004).
4.5. Economical–botanical aspects
Hibiscus is available from China, Thailand, Sudan, Mexico and
some other countries with smaller suppliers like Egypt, Senegal,
Tanzania, Mali and Jamaica.
Hibiscusquality stronglydependsongeographic origin. Themost
desirable product is from Thailand and Sudan; however the main
world suppliers are China and Thailand. The bestHs grows in Sudan,
however its quality is subsequently often impaired due to poor pro-
cessing. Thailand has invested greatly in Hibiscus production con-
trary to China, where the product is less reliable and reputable due
to less stringent quality control practices. However, China is the
dominant supplier of the United States market (Cooper, 1993;
McCaleb, 2000; Mohamed, Sulaiman, & Dahab, 2012; Plotto, 2004).
4.6. FairTrade certiﬁed and organic certiﬁed
Until very recently, the Arab Republic of Egypt was the only
source country for certiﬁed and organic certiﬁed hibiscus ﬂower.
In 2011 a number of producers and traders from Burkina Faso
achieved certiﬁcation through the FairTrade Labelling Organisa-
tions International FLO-CERT GmbH (http://www.ﬂo-cert.net)
(Brinckmann, 2011).
5. Phytochemistry
5.1. Nutritional value
The nutritional composition of fresh cHs varies between studies,
probably due to different varieties, genetic, environmental, ecology
and harvest conditions of the plant. Early studies reported that cHs
contains protein (1.9 g/100 g), fat (0.1 g/100 g), carbohydrates
(12.3 g/100 g) and ﬁbre (2.3 g/100 g). They are rich in vitamin C
(14 mg/100 g), b-carotene (300 lg/100 g), calcium (1.72 mg/
100 g) and iron (57 mg/100 g) (Ismail, Ikram, & Nazri, 2008).
The leaves contain protein (3.3 g/100 g), fat (0.3 g/100 g), carbo-
hydrate (9.2 g/100 g), minerals (phosphorus (214 mg/100 g), iron
(4.8 mg/100 g) thiamine (0.45 mg/100 g), b-carotene (4135 lg/
100 g), riboﬂavin (0.45 mg/100 g) and ascorbic acid (54 mg/100 g)
(Ismail, Ikram, & Nazri, 2008).
The seeds contained crude fatty oil (21.85%), crude protein
(27.78%), carbohydrate (21.25%), crude ﬁbre (16.44%) and ash
(6.2%). In terms of minerals, the most prevalent is potassium(1329 ± 1.47 mg/100 g), followed by sodium (659 ± 1.58 mg/
100 g), calcium (647 ± 1.21 mg/100 g), phosphorus (510 ± 1.58
mg/100 g) and magnesium (442.8 ± 1.80 mg/100 g). The major sat-
urated fatty acids identiﬁed in the seed oil are palmitic (20.84%)
and stearic (5.88%) acids and the main unsaturated fatty acids
are linoleic (39.31%) and oleic acid (32.06%) (Nzikou et al., 2011).
5.2. Bioactive constituents
The main constituents of H. sabdariffa relevant in the context of
its pharmacological are organic acids, anthocyanins, polysaccha-
rides and ﬂavonoids (Eggensperger & Wilker, 1996; Müller &
Franz, 1990).
5.3. Organic acids
Hs extracts contain a high percentage of organic acids, including
citric acid, hydroxycitric acid, hibiscus acid, malic and tartaric
acids as major compounds, and oxalic and ascorbic acid as minor
compounds. Based on previous studies, the percentage of organic
acids in ‘‘hibisci ﬂos’’ varies; hibiscus acid accounts for 13–24%,
citric acid 12–20%, malic acid 2–9%, tartaric acid 8% and 0.02–
0.05% of ascorbic acid (vitamin C) (Eggensperger & Wilker, 1996;
Schilcher, 1976).
In the late 1930s, citric and malic acids were ﬁrst reported in
aqueous extracts of the calyx (Buogo & Picchinenna, 1937;
Indovina & Capotummino, 1938; Reaubourg & Monceaux, 1940)
and also inﬁve different strains (fromEgypt, Senegal, India, Thailand
and Central America) of Hs var. sabdariffa (Khafaga, Koch, El Afry, &
Prinz, 1980). Ascorbic acid is alsopresent in cHsbut its content varies
dramatically between fresh (6.7–14 mg/100 g (Ismail, Ikram, &
Nazri, 2008; Morton, 1987)) and dried calyces (260–280 mg/100 g
(Ismail, Ikram, & Nazri, 2008)). The amount of ascorbic acid in the
latter report being much higher than the ones previously reported
in the literature. The differences observed might be due to different
varieties, genetics, environment, ecology and harvest conditions.
5.3.1. Hydroxycitric acid
(Fig. 1) has an additional hydroxyl group at the second carbon of
citric acid. This acid has four stereoisomers, (2S, 3S), (2R, 3R), (2S,
3R) and (2R, 3S), and their lactone forms. The principal organic acid
found in the cHs is the (2S, 3R)-hydroxycitric acid (Hida, Yamada, &
Yamada, 2007). It is the principal organic acid found in the calyces
of Hs. It is worth noting that, (2S, 3R)-hydroxycitric acid from
Hibiscus is different from the more commonly known (2S,3S)-
hydroxycitric acid (HCA) extracted from, e.g., Garcinia sp., thus
raising the question as to whether both diastereomers have identi-
cal or partially different pharmacological proﬁles.
5.3.2. Hibiscus acid
(Fig. 1) is the lactone form of (+)-allo-hydroxycitric acid. It com-
promises a citric acid moiety with an additional hydroxyl group at
the second carbon and has two diastereomers due to the existence
of two chiral centers in the molecule (Boll, Sørensen, & Balieu,
1969; Eggensperger & Wilker, 1996; Griebel & Lebensm, 1939,
1942).
Hydroxycitric acid, hibiscus acid and it derivatives as the
major organic acids in the leaves and calyces extracts of Hs
(Beltran-Debon et al., 2010; Herranz-Lopez et al., 2012; Peng
et al., 2011; Ramirez-Rodrigues, Balaban, Marshall, & Rouseff,
2011a,b; Rodriguez-Medina et al., 2009).
5.3.3. Anthocyanins
The anthocyanins are a group of ﬂavonoid derivatives and nat-
ural pigments present in the dried ﬂowers of Hs and their colour
varies with pH.
Fig. 1. Citric acid and its derivatives.
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din-3-sambubioside (hibiscin), cyanidin-3-sambubioside (gossypi-
cyanin), cyanidin-3,5-diglucoside, delphinidin (anthocyanidin) and
others (Williamson, Driver, & Baxter, 2009).
The ﬁrst anthocyanin from the calyx of Hs to be isolated was
‘‘hiviscin’’, also known as ‘‘hibiscin’’, later named delphinidin-3-
sambubioside and assigned the structure of cyanidin-3-glucoside
(Yamamoto & Osima, 1932), which was later renamed as delphini-
din-pentoside-glucoside (Yamamoto & Osima, 1936). From the pig-
ments of cHs, three different anthocyanins were isolated:
delphinidin-3-sambubioside (hibiscin), delphinidin-3-glucoside
and cyanidin-3-glucoside (chrysanthenin) (Fig. 2) using material
from Taiwan and Trinidad (Du & Francis, 1973; Shibata &
Furukawa, 1969). The last study also identiﬁed cyanidin-3-sambu-
bioside (gossypicyanin) (Fig. 2). Later, the presence of cyanidin-3,
5-diglucoside and cyanidin-3-(2G-glucosylrutinoside) in the ﬂower
pigments of Hs var. altissima (Subramanian & Nair, 1972) was
reported. A study conducted with 5 different strains of Hs var.
sabdariffa reported cyanidin-3-sambubioside and cyanidin-3-glu-
coside as the major compounds present in this plant (Khafaga,
Koch, El Afry, & Prinz, 1980). In one of the strains (Senegalese
strain), delphinidin glycosides were absent. In this study, the antho-
cyanin content reached 1.7% to 2.5% of the dry weight in all strains.
A similar anthocyanin content was observed in another study
where their amount was about 1.5 g per 100 g of dry weight of
cHs, in terms of delphinidin-3-sambubioside (Du & Francis, 1973).
Several studies have identiﬁed delphinidin-3-sambubioside
(delphinidin-3-O-(2-O-b-D-xylopyranosyl)-b-D-glucopyranoise) and
cyanidin-3-sambubioside (cyanidin-3-O-(2-O-b-D-xylopyranosyl)-
b-D-glucopyranoside) as themajor anthocyanins present in extractsFig. 2. Chemical structures of main anthocyanins.from cHs (Alarcon-Aguilar et al., 2007; Alarcon-Alonso et al., 2012;
Beltran-Debon et al., 2010; Degenhardt, Knapp, & Winterhalter,
2000; Herranz-Lopez et al., 2012; Peng et al., 2011) and leaves
(Rodriguez-Medina et al., 2009).5.3.4. Flavonoids
Hs contain polyphenols of the ﬂavonol and ﬂavanol type in
simple or polymerised form. The following ﬂavonoids have been
described in Hs extracts: hibiscitrin (hibiscetin-3-glucoside),
sabdaritrin, gossypitrin, gossytrin and other gossypetin glucosides,
quercetin and luteolin (McKay, 2009; Williamson et al., 2009); as
well as chlorogenic acid, protocatechuic acid, pelargonidic acid,
eugenol, quercetin, luteolin and the sterols b-sitosterol and
ergosterol (McKay, 2009; Williamson et al., 2009).
Earlier the ﬂowers of Hs were recorded to contain 3-monog-
lucoside of hibiscetin (hibiscitrin) (Rao & Seshadri, 1942a,b,
1948), 7-glucoside of gossypetin (gossypitrin) and sabdaritrin,
which on acid hydrolysis yielded an hydroxyﬂavone named sab-
daretin (Rao & Seshadri, 1942a,b). The presence of these ﬂavonol
glycosides was low, with hibiscitrin being the major compound fol-
lowed by gossypitrin and sabdaritrin (Rao & Seshadri, 1942a,b). In
1961, gossypetin-3-glucoside (gossytrin) was isolated (Seshadri &
Thakur, 1961). The petals of Hs var. altissima also contain gossype-
tin-8-glucoside (0.4%) and gossypetin-7-glucoside (Subramanian &
Nair, 1972).
From the leaves of Hs, b-sitosteryl-b-D-galactoside (Osman,
El-Garby-Younes, & Mokhtar, 1975) and from the seeds ergosterol
(Salama & Ibrahim, 1979) were reported. b-sitosterol and ergos-
terol were also reported in Hs extracts (McKay, 2009; Williamson
et al., 2009).
The methanolic extract of the ﬂowers also contains quercetin,
luteolin and its glycoside (Salah, Gathumbi, & Vierling, 2002).
Quercetin had already been identiﬁed in Hs (Takeda & Yasui,
1985). One study reported that the amount of quercetin present
in cHs WE was 3.2 mg/g while rutin was 2.1 mg/g (Alarcon-
Alonso et al., 2012). Quercetin and its conjugated glycosides (quer-
cetin-3-glucoside), as well as, rutin (quercetin-3-rutinoside; Fig. 3)
were frequently identiﬁed in cHs WE, alongside with kaempferol
(Beltran-Debon et al., 2010; Herranz-Lopez et al., 2012; Peng
et al., 2011; Ramirez-Rodrigues, Balaban, Marshall, & Rouseff,
2011a,b).
The water extract of the dried leaves showed the presence of
catechin (4.25%) and ellagic acid (28.20%) (Lin et al., 2012), while
cHs WE showed the presence of protocatechuic acid (24.24%),
catechin (2.67%), gallocatechin (2.44%), caffeic acid (19.85%),
gallocatechin gallate (27.98%) (Yang et al., 2010). Similar results
were reported by Huang and co-workers (Huang et al., 2009).
Phenolic acid: Protocatechuic acid (PCA) is an important pheno-
lic acid present in Hs extract (Fig. 4) (Lee et al., 2002; 2003; McKay,
Fig. 3. Quercetin-3-rutinoside.
Table 1
Overview on constituents in H. sabadriffa calyces water extract.
Class Compound References
Organic acid
Hydroxycitric acid 1, 4
Hibiscus acid 1, 2, 3, 4
Hibiscus acid glucoside 3
Hibiscus acid 6-methyl ester 2, 3, 4
Anthocyanins
Delphinidin-3-sambubioside 1, 2, 4
Cyanidin-3-sambubioside 1, 2, 4
Flavonoids and phenolic acid
Gallic acid 2, 3
Chlorogenic acid isomer I 1
Chlorogenic acid 1, 2, 4
Chlorogenic acid isomer II 1
5-Hydroxymethylfurfural 2
Methyl gallate 4
2-O-trans-Caffeoyl-hydroxicitric acid 4
5-Caffeoylquinic acid 2, 3
Myricetin-3-arabinogalactoside 1, 4
3-Caffeoylquinic acid 3
Protocatechuic acid 2
Protocatechuic acid glucoside 3
Coumaroylquinic acid 4
Quercetin-3-sambioside 1, 4
Quercetin-3-rutinoside 1, 3, 4
5-O-Caffeoylshikimic acid 1, 4
Leucoside(kaempferol-3-O-sambubioside) 4
Quercetin-3-glucoside 1, 4
Kaempferol-3-O-rutinoside 1, 4
Feruloyl derivative 2
Methyl(AS in Methylepigallocatechin) 4
Myricetin 4
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ﬂowers of Hs and assigned the structure of 3,4-dihydrobenzoic
acid) (Osman, El-Garby-Younes, & Mokhtar, 1975; Tseng, Wang,
Kao, & Chu, 1996).
Chlorogenic acid is another phenolic acid present in both leaf
and cHs extracts and belongs to a family of esters formed between
certain trans-cinnamic acids (caffeic acid, ferulic acid and
p-coumaric acid) and quinic acid (Clifford, Johnston, Knight, &
Kuhnert, 2003). Several studies reported the presence of this acid
and its derivatives in extracts of cHs (Beltran-Debon et al., 2010;
Herranz-Lopez et al., 2012; Peng et al., 2011; Ramirez-Rodrigues,
Balaban, Marshall, & Rouseff, 2011a,b; Salah et al., 2002) and leaves
(Rodriguez-Medina et al., 2009). In one study, the amount of
chlorogenic acid in the extract was reported to be 2.7 mg/g
(Alarcon-Alonso et al., 2012).
5.3.5. Mucilage, pectin and carbohydrates (polysaccharides)
Polysaccharides are another key group of compounds present
in large quantities in the cHs WE. In one study, the ethanol-
precipitated water extract yielded 10% of reddish polysaccharides.
The following compounds were identiﬁed in two different
fractions, arabinose, galactose, glucose, rhamnose and smaller
amounts of galacturonic acid, glucuronic acid, manose and xylose
(Müller, Kraus, & Franz, 1989). Similar results were obtained in
two other studies (Brunold et al., 2004; Müller & Franz, 1992).
The mucilage content was determined in the calyces of ﬁve
strains of Hs var. sabdariffa, reaching 24–28% in strains from
Central America and Egypt but only 15% in an Indian strain. This
amount was only reached at a later stage of development in the
strains from Senegal and Thailand. The pectin content only
accounted for 2–4% while the sugars reached a maximum of
3–5% in these ﬁve strains. Mucilage and pectin consisted of
60–80% anhydrouronic acid (Afry, Khafaga, Koch, & Prinz, 1980).
The petals of Hs yielded 65% of dry weight of mucilage, which
on hydrolysis produced galactose, galacturonic acid and rhamnose,
while the leaves only yield 10% (El-Hamidi, Saleh, & Ahmed, 1967;
Sengupta & Banik, 2011).
5.3.6. Volatile compounds
Volatile compounds are responsible for the aroma of Hs. In a
study conducted in 1992, more then twenty-ﬁve volatile com-
pounds (accounting for less than 8% of total Hs seeds composition)Fig. 4. Protocatechuic acid.were reported in seed oil of Hs. They were mainly unsaturated
hydrocarbons, alcohols and aldehydes from C8 to C13. (Jirovetz
et al., 1992) Subsequently, thirty-seven volatile compounds from
ﬁve different groups from the cHs WE were characterised. These
compounds included fatty acid derivatives (such as 2-ethylfuran
and hexanal), sugar derivatives (furfural and 5-methyl-2-furalde-
hyde), phenolic derivatives (eugenol), terpenes (such as 1,4-cine-
ole, limonene) and miscellaneous compounds (e.g. acetic acid)
(Chen, Huang, Ho, & Tsai, 1998). In another study, the volatile pro-
ﬁle was examined in four aqueous extracts from fresh and dried
calyx using two different, time–temperature extraction conditions
by GC–MS. A total of thirty-two compounds were identiﬁed and
could be divided into ﬁve chemical groups: aldehydes (fourteen
compounds), alcohols (ten compounds), ketones (ﬁve compounds),
terpenes (two compounds) and acids (one compound) (Ramirez-
Rodrigues, Balaban, Marshall, & Rouseff, 2011a,b). A total of seven
aromatic volatiles were common to all four samples tested (hex-
anal, 3-octanone, octanal, 1-octen-3-one, nonanal, 2,4-nonadienal
(E,E), and geranylacetone).
The following table (Table 1) shows an overview on the constit-
uents present in H. sabdariffawater extract (cHsWE), which are rel-
evant for use in herbal teas, detected on RP HPLC coupled with the
photodiode array detection (DAD) and ESI-TOF-MS in positive and
negative mode.N-Feruloyltyramide 1, 4
4-Caffeoylquinic acid 2, 3
Caffeoylquinic acid isomer 3
Kaempferol-3-p-coumarylglucoside 1
Quercetin 1, 4
Caffeic acid 2
Galloyl ester 2
Feruloyl quinic acid derivative
Kaempferol-3-glucoside 2
Quercetin derivative 2
Tiliroside 2
Legend: 1 – Beltran-Debon et al. (2010); 2 – Peng et al. (2011); 3 – Ramirez-
Rodrigues, Balaban, Marshall, & Rouseff, (2011a,b); 4 – Herranz-Lopez et al. (2012).
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macological actions of Hs extract (next section), the polyphenol
content of the extract was, for some activities, reported as the
one responsible for the effect. Nevertheless, the polyphenol con-
tent is a very general and often poorly deﬁned term, as it includes
a complex mixture of anthocyanins, organic acids, phenolic acids
and ﬂavonoid compounds.6. Biological and pharmacological activities
A detailed review of the pharmacological effects of Hs extracts is
presented in this section with additional information on the
studies reviewed in the supplementary data (Supplementary
Tables 1–15) section.
6.1. Effects on smooth muscles
Early studies showed that the alcoholic extract of Hs ﬂowers
had an antispasmodic effect by relaxing the uterus and intestine
stips in vitro (Sharaf, 1962). This was also observed in rabbit aortic
smooth muscle (Obiefuna, Owolabi, Adegunloye, Obiefuna, &
Sofola, 1994). Interestingly, from various isolated muscle prepara-
tions, the extract of Hs inhibited the tone of rabbit aortic strip,
rhythmically contracting rat uterus, guinea-pig tracheal chain
and rat diaphragms, but it stimulated the tone of solated quiescent
rat uterus and frog rectus abdominis (Ali, Salih, Mohamed, &
Homeida, 1991).
More recently, the Hs WE (1–100 mg/kg) was found to inhibit
rat bladder and uterine contractibility in a dose dependent manner,
but via a mechanism unrelated to local or remote autonomic
receptors or calcium channels (Fouda, Daba, & Dahab, 2007) as pre-
viously suggested by Salah (Salah et al., 2002).
Later, it was shown that Hs crude extracts mainly induced the
endothelium-dependent relaxant effect in the isolated thoracic
aorta of rats, via stimulation of NOS enzyme by the Pi3-K/Akt path-
way. It was suggested that this was due to polyphenols. The non-
endothelium dependent relaxation is a direct smooth muscle acti-
vation and results in the activation of smooth muscle potassium
channels (Sarr et al., 2009).
6.2. Antibacterial, antifungal and antiparasitic activity
The cHs WE and protocatechuic acid (5 mg/ml) inhibited the
growth of methicillin-resistant Staphylococcus aureus, Klebsiella
pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii
(Liu, Tsao, & Yin, 2005). Moreover, protocatechuic acid (in a dose
dependent manner) showed greater antimicrobial activity against
these pathogens in broth than in human plasma. The study also
revealed that the antibacterial effect was independent from
temperature, as shown by a heat treatment. Hibiscus extract also
demonstrated antibacterial effect against Streptococcus mutans,
cariogenic bacteria from the oral cavity, with a minimum inhibi-
tory concentration of 2.5 mg/ml (Afolabi, Ogunsola, & Coker,
2008) and Campylobacter species (Campylobacter jejuni, Campylo-
bacter coli and Campylobacter fetus) that contaminates meat like
poultry, beef and pork at a concentration range of 96–152 lg/ml
(Yin & Chao, 2008). This time, the aqueous-methanol extract of
dried cHs also showed an in vitro inhibitory effect against several
bacterial strains, such as S. aureus, Bacillus stearothermophilus,
Micrococcus luteus, Serratia mascences, Clostridium sporogenes,
Escherichia coli, K. pneumonia, Bacillus cereus and Pseudomonas ﬂuo-
rescence, but did not effect the growth of fungus Candida albicans
(Olaleye, 2007). The fresh cHs WE, ethanol extract and proto-
catechuic acid (20 mg/ml) was effective in inhibiting the growth
of food spoilage bacteria such as Salmonella typhimurium DT104,E. coli O157:H7, Listeria monocytogenes, S. aureus and B. cereus.
Again the antibacterial effect was not affected by heat treatment
and the ethanolic extract showed greater antimicrobial effect
than the aqueous extract. The study further suggests that both,
ethanolic extract and protocatechuic acid, might be potent agents
for use as food additives to prevent contamination from these
bacteria (Chao & Yin, 2009; Yin & Chao, 2008).
A methanol-water extract of Hs was effective against E. coli
O157:H7 isolates from food, veterinary and clinical samples
(Fullerton, Khatiwada, Johnson, Davis, & Williams, 2011), with
the highest concentration (10%) being the most effective.
The crude extracts of Hs seeds (200 mg/l) also showed antimi-
crobial effect against three types of Gram-negative bacteria. The
extract exhibited higher activity against Salmonella followed by
Shigella and Enterobacter (Nwaiwu, Mshelia, & Raufu, 2012).
6.3. Antipyretic, antinociceptic and anti-inﬂammatory activities
Despite the claims that Hs is effective in the relief of pyrexia in
popular medicines, limited studies are available. The antipyretic
and anti-inﬂammatory potential of the cHs extract were studied
in vivo. The ethanol (more potent) and aqueous extracts showed
antipyretic effects by signiﬁcantly reversing yeast-induced fever
in rats. The mechanism is different from the one of aspirin, a pros-
taglandin inhibitor. Nevertheless, fever entails enhanced formation
of cytokines such as interleukins (IL), interferons and tumour
necrosis factor-a (TNF-a). The cHs extract may be involved in the
inhibition of some of these substances, resulting also in an anti-
inﬂammatory effect (Reanmongkol & Itharat, 2007). Similar results
were obtained by Dafallah (Dafallah & al-Mustafa, 1996), suggest-
ing that the ﬂavonoids, polysaccharides and organic acids might be
the compounds responsible for the pharmacological activity. In a
more recent study the ethanolic extract from the calyces also
showed antinociceptive effect in a rat model (Ali, Ashraf, Biswas,
Karmakar, & Afroz, 2011).
Another in vivo study showed that the two fractions of the crude
aqueous-ethanolic extract of the dried cHs exhibited impressive
immunostimulatory activity by increasing the production of
IL-10 and decreasing the production of TNF-a (Fakeye, 2008).
Another mechanism in which the polyphenol extract exhibit its
anti-inﬂammatory activity is by impairing cyclooxygenase-2 induc-
tion by down-regulating JNK and p38 MAPK (Kao et al., 2009).
6.4. Clinical studies
A study conducted with 10 healthy volunteers also supports the
claim for its anti-inﬂammatory activity. The ingestion of cHs WE
(dried) decreased plasma monocyte chemoattractant protein 1
(MCP-1) concentration, a biomarker in the evaluation of
inﬂammatory diseases (Beltran-Debon et al., 2010).
6.5. Antioxidant activity
Several studies both in vitro (Duh & Yen, 1997; Farombi &
Fakoya, 2005; Hirunpanich et al., 2005; Mohd-Esa, Hern, Ismail,
& Yee, 2010; Sayago-Ayerdi, Arranz, Serrano, & Goni, 2007;
Steenkamp, Fernandes, & van Rensburg, 2004; Tseng et al., 1997)
and in vivo (Farombi & Fakoya, 2005; Mossalam, Aty, Morgan,
Youssaf, & Mackawy, 2011; Olalye & Rocha, 2007; Usoh, Akpan,
Etim, & Farombi, 2005) have shown that extracts of Hs have a
potent antioxidant effect.
The antioxidant activity of the extract is due to its strong scav-
enging effect on reactive oxygen and free radicals (Farombi &
Fakoya, 2005; Mohd-Esa, Hern, Ismail, & Yee, 2010; Olalye &
Rocha, 2007; Sayago-Ayerdi, Arranz, Serrano, & Goni, 2007; Tseng
et al., 1997; Usoh, Akpan, Etim, & Farombi, 2005), inhibition of
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hydroperoxide (t-BHP)-induced oxidative damage (Tseng et al.,
1997), protection of cell from damage by lipid peroxidation (Duh
& Yen, 1997; Farombi & Fakoya, 2005; Olalye & Rocha, 2007), inhi-
bition in Cu2+-mediated oxidation of LDL and the formation of thio-
barbituric acid reactive substances (TBARs) (Hirunpanich et al.,
2005; Ochani & D’Mello, 2009; Olalye & Rocha, 2007), inhibition
of the formation of malondialdehyde content (100–300 mg/kg)
(Farombi & Fakoya, 2005; Usoh, Akpan, Etim, & Farombi, 2005),
reduction of glutathione depletion, increase of the liver and
decrease blood activity of superoxide dismutase and catalase
(Usoh, Akpan, Etim, & Farombi, 2005) while in the liver it increased
superoxide dismutase, catalase and glutathione and decreasedmal-
ondialdehyde (Mossalam, Aty, Morgan, Youssaf, & Mackawy, 2011).
The effects were observed for both water and ethanolic extracts
from ﬂowers of Hs, as well as from the seeds or leaves (Mohd-Esa,
Hern, Ismail, & Yee, 2010).
6.6. Clinical studies
One single randomised, open-label, two-way cross-over study
was conducted with 8 healthy volunteers. One single dose
(0.05 g/ml) of a Hs WE signiﬁcantly increased the systemic antiox-
idant potential in plasma and urine, increasing the hippuric acid
excretion with decreased malondialdehyde concentration in urine
(biomarker for oxidative stress) (Frank et al., 2012).
Polyphenols in particular the anthocyanins (eg. delphinidin-3-
glucoside) and protocatechuic acid (Degenhardt et al., 2000;
Mohd-Esa, Hern, Ismail, & Yee, 2010; Sayago-Ayerdi, Arranz,
Serrano, & Goni, 2007; Tseng et al., 1997) are key classes of com-
pounds linked to the antioxidant activity. This activity is also the
basis of many other activities including hepatoprotective and
nephroprotective activities from the extract.
6.7. Hepatoprotective activity
cHs WE (100–800 mg/kg) showed hepatoprotective effects in a
range of models based on toxin-induced hepatitis including, tert-
butylhydroperoxide, lipopolysaccharides, azathioprine, carbon tet-
rachloride, cadmium, ammonium chloride, acetaminophen and
irradiation in vivo (Adaramoye, Ogungbenro, Anyaegbu, &
Fafunso, 2008; Ajiboye et al., 2011; Ali, Mousa, & El-Mougy,
2003; Amin & Hamza, 2005; Asagba, Adaikpoh, Kadiri, & Obi,
2007; Essa et al., 2006; Lin et al., 2003; Liu, Wang, Chu, Cheng, &
Tseng, 2002, 2010; Liu et al., 2006; Olaleye & Rocha, 2008; Tseng,
Wang, Kao, & Chu, 1996; Wang et al., 2000) and in vitro (Ajiboye
et al., 2011; Lee et al., 2012; Yin, Cao, Xu, Jeney, & Nakao, 2011).
This effect is due to a strong antioxidant activity, which reduces
cellular damage by reducing oxidative stress and by attenuating
mitochondrial dysfunction through decreasing Bax and tBid
expression in the liver (Lee et al., 2012). The extract also increased
the activity of superoxide dismutase (SOD), catalase (CAT), glutha-
thione peroxidase (GPx), and d-aminolevulinate dehydratase
(d-ALA-D) enzymes while decreasing lipid peroxidation in induced
models of liver damage (Adaramoye, Ogungbenro, Anyaegbu, &
Fafunso, 2008; Ajiboye et al., 2011; Olaleye & Rocha, 2008), and
decreased liver marker enzymes such as aspartate transaminase
(AST), alanine transaminase (ALT) and alkaline phosphatase (ALP)
in experimental hyperammonemia (Essa et al., 2006). An Hibiscus
anthocyanin extract also induced phase II drug-detoxifying
enzymes, such as glutathione S-transferase, NAD(H):quinone oxi-
doreductase, and uridyl diphosphoglucuronosyl transferase in an
induced liver damage model (CCl4-mediated toxicity model)
(Ajiboye et al., 2011).
The anthocyanins present in the extract seem to be the ones
responsible for this effect (Ajiboye et al., 2011; Ali et al., 2003;Wang et al., 2000). Another compound that has been identiﬁed
to have this effect was protocatechuic acid, a phenolic compound
present in the Hs extract (Lin et al., 2003; Liu, Wang, Chu, Cheng,
& Tseng, 2002; Tseng, Wang, Kao, & Chu, 1996).
6.8. Nephroprotective activity
Two studies were reported on the nephroprotective activity of
Hs extracts on diabetic nephropathy in streptozotocin-induced
type 1 diabetic rats (Lee et al., 2009; Wang et al., 2011). Nephrop-
athy may progress to end-stage renal disease. A study was con-
ducted to investigate the effect of the polyphenol extract of Hs
(100 and 200 mg/kg/day) in streptozotocin-induced diabetic
nephropathy in rats. The extract revealed beneﬁcial effects as the
kidney mass was reduced and the hydropic change of renal proxi-
mal convoluted tubules was improved, it reduced serum triglycer-
ide, total cholesterol and LDL as well as increased the activity of
catalase and glutathione and reduced lipid peroxidation in the kid-
ney (Lee et al., 2009). It was found that the extracts reduced kidney
mass and improved hydropic change of renal proximal convoluted
tubules in this rat model. The positive effect shown by the extracts
might be via improving oxidative status and regulating Akt/Bad/
14-3-3c signalling (anti-apoptotic mechanisms). Another in vivo
study also revealed that its nephroprotective effect is a result of
the protection of the kidney from the oxidative stressed
(Mossalam, Aty, Morgan, Youssaf, & Mackawy, 2011).
6.9. Renal effects/diuretic effect (incl. clinical studies)
The renal effect of Hs has been characterised pharmacologically
both in clinical trials (Herrera-Arellano, Flores-Romero,
Chávez-Soto, & Tortoriello, 2004; Kirdpon, Nakorn, & Kirdpon,
1994; Prasongwatana, Woottisin, Sriboonlue, & Kukongviriyapan,
2008) and in pre-clinical experiments in rats (Aguwa, Ndu,
Nwanma, Udeogaranya, & Akwara, 2004; Laikangbam &
Damayanti Devi, 2012).
A two-phase study in Thailand with thirty-six healthy men was
conducted to evaluate the changes in urine after consumption of Hs
juice (16 g/day and 24 g/day) to determine its effect on the treat-
ment and prevention of renal stones. Despite the fact that the con-
sumption of Hs caused a decrease in creatinine, uric acid, citrate,
tartrate, calcium, sodium, potassium and phosphate it did not
affect the concentration of oxalate in urinary excretion. The
authors suggested that there was no beneﬁcial effect in preventing
renal stone formation and that long term and higher doses should
be investigated (Kirdpon et al., 1994). Another intervention study
carried out in Thailand with eighteen subjects with or without his-
tory of renal stones revealed that Hs tea drinking, at a dose of 3 g/
day for 15 days, did not show evidence for antilithiatic or diuretic
effects. No signiﬁcant difference in serum sodium and urinary vol-
ume were observed during this study. However, Hs tea consump-
tion produced a uricosuric effect (Prasongwatana, Woottisin,
Sriboonlue, & Kukongviriyapan, 2008). Similar results were
observed in albino rats when given a decoction of dried calyces
at an oral dose of 1 g/kg (Caceres, Giron, & Martinez, 1987).
However, in vivo an antilithiatic effect was observed. In Wistar
rats, which were given extract of Hs orally at a dose of 3.5 mg daily,
the oxalate retention in the kidney decreased with increased
excretion into urine and decreased calcium crystal deposition in
the kidneys (Woottisin et al., 2011). The cHs WE (250, 500 and
750 mg/kg body weight) also effectively prevented the develop-
ment of urolithiasis (stone-disorder) in male albino rats
(Laikangbam & Damayanti Devi, 2012). A decrease in renal Ca2+
and Mg2+-ATPase activity and unaltered renal calcium handling
in rats after administration of cHs WE at 25 and 50 mg/kg was
shown. Renal function was also enhanced by reduction of serum
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Olatunji, 2012). In another pre-clinical study in rats, cHs WE pro-
duced diuretic and natriuretic effects at the dose range of 500 to
2500 mg/kg b.w. with a potassium-sparing effect (Alarcon-Alonso
et al., 2012). This diuretic effect is in accordance with previous
studies in experimental animals (Aguwa, Ndu, Nwanma,
Udeogaranya, & Akwara, 2004; Caceres et al., 1987; Onyenekwe,
Ajani, Ameh, & Gamaniel, 1999; Ribeiro Rde et al., 1988) and one
clinical trial (Herrera-Arellano, Flores-Romero, Chávez-Soto, &
Tortoriello, 2004). In this single clinical trial, assessing a chemically
characterised extract of Hs (9.6 mg of total anthocyanins) in
patients with mild to moderate hypertension, the treatment dem-
onstrated a natriuretic effect with no effects on chloride, potassium
and pH (Herrera-Arellano, Flores-Romero, Chávez-Soto, &
Tortoriello, 2004).
6.10. Cancer-preventive activity
Hs is rich in phenolic compounds, such as protocatechuic acid.
This compound demonstrated in vitro protective effects against
cytotoxicity and genotoxicity of hepatocytes induced by tert-butyl-
hydroperoxide (t-BHP), through inhibiting action on DNA repair
synthesis caused by t-BHP and by showing radical quenching effect
(Tseng, Wang, Kao, & Chu, 1996). It also inhibited 12-O-tetradecan-
olyphorbol-13-acetate (TPA)-induced skin tumour formation in
CD1-mice (Tseng et al., 1998) and inhibited the survival of human
promyelocytic leukaemia HL-60 cells (Tseng et al., 2000). The
mechanism by which it exerted anticancer properties might be
through antitumour promotion by reducing reactive oxygen spe-
cies (ROS), DNA fragmentation, G1 arrest and apoptosis. The apop-
tosis-inducing activity was associated with the phosphorylation
and degradation of RB and the suppression of Bcl-2 protein. Similar
effects were observed in human gastric carcinoma (AGS) cells in
which the apoptotic effect may be mediated via p53 signaling and
p38 MAPK/FasL cascade pathway (Lin, Huang, Huang, Chen, &
Wang, 2005). Another group of compounds present in cHs extracts
are anthocyanins such as delphinidin-3-sambubioside. They
induced apoptosis against human leukaemia cells (Chang, Huang,
Hsu, Yang, & Wang, 2005; Hou, Tong, Terahara, Luo, & Fujii, 2005)
via the p38-FasL and Bid pathway and ROS-mediated mitochondrial
dysfunction pathway and against smooth muscle cells (SMC) via
p38 and p53 pathway (Lo, Huang, Lin, Chien, & Wang, 2007).
Recently, the anti-cancer activity of Hs leaf extracts were
assessed against human prostate cancer cells in vitro and in vivo
(Lin et al., 2012). The study showed the anti-apoptotic effect to
be mediated via both intrinsic (Bax/cytochrome c-mediated cas-
pase 9) and extrinsic (Fas-mediated caspase 8/t-Bid) pathways, as
well as by inhibiting the growth of prostate tumour xenograft in
athymic nude mice. The extract from leaves instead of calyces rep-
resented a possible source of greater polyphenolic compounds.
6.11. Lipid metabolism – anticholesterol effects/effects on lipid
metabolism
Several studies have showed that extracts of Hs have a lipid
lowering activity, which could prevent diseases like hyperlipid-
emia and cardiovascular diseases (atherosclerosis and coronary
heart disease) (Carvajal-Zarrabal et al., 2005; Chang, Huang,
Huang, Ho, & Wang, 2006; Chen et al., 2003, 2004; el-Saadany
et al., 1991; Gosain et al., 2010; Hirunpanich et al., 2006; Ochani
& D’Mello, 2009; Yang et al., 2010).
The extracts (water and ethanolic extracts of dried calyces or
leaves) were able to decrease low-density lipoprotein cholesterol
(LDL-c), triglycerides (TAG), total cholesterol (TC) and lipid peroxi-
daxion in vivo. A few of them even reported that the extractwas also
able to reduce very-low density lipoprotein cholesterol (VLDL-c)(Farombi & Ige, 2007; Ochani & D’Mello, 2009) along with an
increase in serum level of high density lipoprotein cholesterol
(HDL-c) levels (Ochani & D’Mello, 2009; Yang et al., 2010). Addition-
ally, it also reduced foam cell formation and inhibited smooth mus-
cle cellmigrationand calciﬁcation inbloodvessels of treated rabbits.
A possible explanation for the decrease in LDL-c could be related to
the inhibitionof the triacylglycerol synthesis or otherhypolipidemic
effects, through the antioxidant activity against LDL-c oxidation and
hepatic liver clearance. Several groups of compounds in the extract,
such as anthocyanins andprotocatechuic acid, have been implicated
as responsible for these effects (Chang, Huang, Huang, Ho, & Wang,
2006; Lee et al., 2012; Tseng et al., 1997).
6.12. Clinical studies
In one clinical trial using an oral preparation of Hs ﬂower
extract capsules (with a deﬁned composition) serum cholesterol
level was reduced after 4 weeks. The best results were obtained
with the dosage of two capsules per meal (Lin et al., 2007). Along
with this study, another randomised clinical trial with 53 patients
with type II diabetes also showed that a tea of Hs had a signiﬁcant
effect on the blood lipid proﬁle. Patients were given Hs (one tea
sachet (2 g) in water) twice a day for a month (Mozaffari-
Khosravi, Jalali-Khanabadi, Afkhami-Ardekani, & Fatehi, 2009a).
Despite this, in one randomised clinical trial, ninety hypertensive
patients were given Hs tea or black tea for 15 days, with the results
showing no hyperlipidemic effect as previously reported in vivo. In
addition, no differences in creatinine level, Na and K electrolytes
were observed after administration of the tea. However, the
short-term administration did not show any harmful effect
(Mohagheghi, Maghsoud, Khashayar, & Ghazi-Khansari, 2011).
Similar results were found in a double-blind placebo controlled
randomised trial with a dose of 1 g/day for 90 days, in which the
leaf ethanol-water extract of Hs did not appear to have a blood
lipid lowering effect over and above the effect of standard dietary
and lifestyle advice (Kuriyan, Kumar, Rajedran, & Kurpad, 2010).
The difference between this clinical trial and the one conducted
in 2007 is that in the second, the ﬂower water extract administered
at a dose of two capsules (1 g) three times a day (total of 3 g/day)
for 30 days signiﬁcantly lowered serum cholesterol levels. Differ-
ences might be due to different dosage being administered, the size
of the test group and duration of the study.
The use of the Hs extract was also assessed in a rat model
(Oppliger et al., 2012) and in patients (Gurrola-Diaz et al., 2010)
with metabolic syndrome. Metabolic syndrome has been charac-
terised as a combination of several metabolic risk factors such as
hypertension, insulin resistance, dyslipidemia, excess adipose tis-
sue and cardiovascular disease. Both studies showed a beneﬁcial
effect of standardised cHs extract on the lipid proﬁle. Consumption
of 100 mg/kg for 6 weeks was able to decrease the total cholesterol
and triglycerides level in rats in a high fat diet, while similar results
were observed in humans taking 100 mg of an extract (1.4 mg/kg)
orally for 30 days. Additionally, the basal HDL-c levels after treat-
ment also increased in human subjects. This increase in HDL-c lev-
els after treatment was also observed in a clinical trial with type II
diabetic patients (Mozaffari-Khosravi, Jalali-Khanabadi, Afkhami-
Ardekani, & Fatehi, 2009a). The anthocyanin content of the extract
has been implicated as responsible for its effects, but an extended
chemical proﬁle characterisation is needed.
6.13. Anti-obesity activity
Pre-clinical data from Brazil indicates a potential role in the
control of certain conditions associated with obesity, such as
hyperlipidemia. However, further studies were suggested (Dickel,
Rates, & Ritter, 2007).
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anins per each 120 mg) water extract of cHs was able to reduce
weight gain in obese mice while at the same time it increase the
liquid intake in healthy and obese mice (Alarcon-Aguilar et al.,
2007). This effect is probably achieved through the modulation of
PI3-K/Akt and ERK pathway, which play pivotal roles during adipo-
genesis (Kim et al., 2007).
In vitro and in vivo studies showed that Hibiscus extract (or tea)
inhibited the activity of a-amylase, blocking sugars and starch
absorption, which may assist in weight loss (Hansawasdi,
Kawabata, & Kasai, 2000, 2001; Preuss, Echard, Bagchi, & Stohs,
2007). A study conducted in Mexico using an ethanol extract of
Hs concluded the extract could be considered as a possible anti-
obesity agent due to its effects on fat absorption-excretion and
body weight of rats (Carvajal-Zarrabal et al., 2009).
The therapeutic use of the extract, possibly due to polyphenols,
was also evaluated in patients with metabolic syndrome, an obes-
ity-associated collection of disorders (Perez-Torres, Ruiz-Ramirez,
Banos, & El-Haﬁdi, 2012). Meanwhile a study showed that the
aqueous extract was more efﬁcient in inhibiting triglyceride accu-
mulation when devoid of ﬁbre and polysaccharides, but when
polyphenols were fractionated and isolated, the beneﬁts of the
whole extract was greater than the sum of its parts (Herranz-
Lopez et al., 2012).
6.14. Lactating activity
The ethanolic seed extract of Hs (200–1600 mg/kg) increased
the serum prolactin level (p < 0.01) when compared to the control
in a dose-dependent manner in lactating Albino Wistar rats (Gaya,
Mohammad, Suleiman, Maje, & Adekunle, 2009).
6.15. Anti-diabetic activity
Diabetes mellitus can be deﬁned as an endocrine and metabolic
disorder characterised by chronic hyperglycaemia, dyslipidemia,
and protein metabolism that results from defects in both regula-
tions of insulin secretion and/or insulin action.
The protective effect of a polyphenol extract of Hs was studied
in a type II diabetic rat model (high fat diet model). At a dose of
200 mg/kg, the extract demonstrated anti-insulin resistance prop-
erties as it reduced hyperglycaemia and hyperinsulinemia. It
decreased serum triacylglycerol, cholesterol and the ratio of low-
density lipoprotein/high-density protein (LDL/HDL), as well as
reduced the plasma advanced glycation end products (AGE) forma-
tion and lipid peroxidation (Peng et al., 2011).
The currently accepted therapeutic strategy for the control of
postprandial hyperglycaemia is based on the inhibition of a-gluco-
sidase and a-amylase. This results in an aggressive delay of carbo-
hydrate digestion to absorbable monosaccharide. With this in
mind, a study was conducted to determine the effect of Hs extract
on intestinal a-glucosidase and pancreatic a-amylase activity
in vitro. As a result, Hs extract was shown to be a potent pancreatic
a-amylase inhibitor (Adisakwattana, Ruengsamran, Kampa, &
Sompong, 2012). Similar results were found for hibiscus acid (hibis-
cus-type (2S,3R)-hydroxycitric acid lactone) (Yamada, Hida, &
Yamada, 2007), which inhibited pancreatic a-amylase and intesti-
nal a-glucosidase enzyme (Hansawasdi et al., 2000, 2001).
Diabetes mellitus is a risk factor for coronary heart diseases as
well as atherosclerosis. An ethnobotanical study conducted in the
Caribbean for urinary problems and diabetes mellitus revealed that
Hs is traditionally used to ‘clean’ the liver and blood within a group
of plants used for ‘‘cooling’’, high cholesterol and urinary problems.
When the respondents were asked which medicinal plants were
used for high blood pressure, diabetes and jaundice, Hs was
referred to hypertension (Lans, 2006). A study in alloxan-induceddiabetic rats showed that an ethanolic extract of Hs ﬂowers
(200 mg/kg) had a strong hypolipidemic as well as antioxidant
effect. Thus, Hs extract showed therapeutic promise in decreasing
and preventing the development of atherosclerosis and possible
related cardiovascular pathologies linked with diabetes. The
authors suggest that this activity might be linked to polyphenolic
compounds and dihydrobenzoic acids, like protocatechuic acids,
but further identiﬁcation of the active compounds is warranted
(Farombi & Ige, 2007). A similar effect was reported (Huang
et al., 2009) with the extract suppressing the high-glucose-induced
migration in a vascular smooth muscle cell model.
6.16. Clinical studies
Recently a double-blind, randomised, controlled trial was car-
ried out to compare the anti-hypertensive efﬁcacy of Hs (tea) in
diabetic patients. The results demonstrated that the consumption
of the sour tea had positive effects on blood pressure in type II dia-
betic patients with mild hypertension (Mozaffari-Khosravi, Jalali-
Khanabadi, Afkhami-Ardekani, Fatehi, & Noori-Shadkam, 2009b).
Following this study another randomised clinical trial (no control
group or double-blinding) in identical patients (100 individuals)
showed that consuming three glasses of green or hibiscus (sour)
tea daily for a period of 4 weeks signiﬁcantly decreased systolic
and diastolic blood pressures in those patients (Mozaffari-
Khosravi, Ahadi, & Barzegar, 2013). However, sodium, potassium
or calcium concentrations were neither qualiﬁed nor speciﬁc
amounts of the other active constituents of tea, such as caffeine,
were taken into consideration. Other clinical trial was conducted
to investigate the hypolipidemic effects of sour tea in patients with
diabetes. Again, the beneﬁcial effect of the sour tea in diabetic
patients was found. The sour tea was able to signiﬁcantly effect
the blood lipid proﬁle by increasing high-density lipoprotein-cho-
lesterol, decreasing total cholesterol, low density lipoprotein-cho-
lesterol, triglycerides and Apo-B100, with no effect on
apolipoprotein-A1 and lipoprotein a (Mozaffari-Khosravi, Jalali-
Khanabadi, Afkhami-Ardekani, & Fatehi, 2009a).
6.17. Delayed puberty activity
A few studies with rats have shown that consumption of Hs WE
during pregnancy and lactation resulted in increased postnatal
weight gain, delayed onset of puberty and elevated body mass
index at onset of puberty in the female offsprings (Iyare &
Adegoke, 2008a,b,c; Iyare & Nwagha, 2009). The consumption of
the extract during pregnancy and lactation caused decrease of
maternal ﬂuid and food intake with increased plasma Na+ and cor-
ticosterone concentration, while the accelerated growth and
delayed puberty observed in the offspring could be due to
increased corticosterone and decreased leptin delivery through
breast milk (Iyare & Adegoke, 2008b; Iyare, Adegoke, & Nwagha,
2010). These studies however require conﬁrmation as no observa-
tions have been reported in the literature up to-date pointing to
the presence of respective effects in humans.
6.18. Anti-hypertensive activity
Decoctions of Hs have been used traditionally in West Africa
and Mexico as an anti-hypertensive remedy. Several in vitro
(Jonadet et al., 1990; Obiefuna, Owolabi, Adegunloye, Obiefuna, &
Sofola, 1994) and in vivo studies have shown that the extract of
the calyces (ranging from 125 to 500 mg/kg) indeed reduce both
the systolic and diastolic pressures, lowering heart rate and work-
ing as a vasodilator (Adegunloye et al., 1996; Ajay, Chai, Mustafa,
Gilani, & Mustafa, 2007; Inuwa et al., 2012; Mojiminiyi et al.,
2007; Onyenekwe, Ajani, Ameh, & Gamaniel, 1999; Shehata & El
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inhibition of angiotensin-converting enzymes (ACE) (Jonadet et al.,
1990; Ojeda et al., 2010), acetylcholine-like and histamine-like
mechanisms (Adegunloye et al., 1996), diuretic effect
(Mojiminiyi, Adegunloye, Egbeniyi, & Okolo, 2000), reduction in
the diffusion distance between capillaries and myocytes, as well
as new vessel formation (Inuwa et al., 2012) and direct vaso-relax-
ant effects (Adegunloye et al., 1996; Ajay, Chai, Mustafa, Gilani, &
Mustafa, 2007; Obiefuna, Owolabi, Adegunloye, Obiefuna, &
Sofola, 1994; Adegunloye et al., 1994). The relaxant effect might
be partially endothelium independent and possibly mediated by
endothelium-derived nitric oxide (EDNO)-dependent action. Endo-
thelium-dependent vasodilator component results through activa-
tion of the endothelium-derived nitric oxide/cGMP-relaxant
pathway, whereas the endothelium-independent component could
be due to inhibition of Ca2+ inﬂux (Ajay, Chai, Mustafa, Gilani, &
Mustafa, 2007).
Additionally, Hs showed antiplatelet but no thrombolytic activ-
ity in vitro (Yamamoto, Yamada, Naemura, Yamashita, & Arai,
2005). One in vivo study reported that despite the beneﬁcial effect
as an anti-hypertensive, Hs might produce undesirable effects on
gonadal activity (Shehata & El Menoufy, 2008).
6.19. Clinical studies
Several clinical trials were carried out to determine the anti-
hypertensive effect of Hs (Haji Faraji & Haji Tarkhani, 1999;
Herrera-Arellano, Flores-Romero, Chávez-Soto, & Tortoriello,
2004; Herrera-Arellano et al., 2007; Mozaffari-Khosravi, Jalali-
Khanabadi, Afkhami-Ardekani, Fatehi, & Noori-Shadkam, 2009b).
Both a Cochrane review and a systematic review carried out in
2010 concluded that the studies did not provided reliable evidence
to support recommendation of this plant to control or lower blood
pressure in hypertensive patients, when compared to placebo or no
treatment (Ngamjarus, Pattanittum, & Somboonporn, 2010;
Wahabi, Alansary, Al-Sabban, & Glasziuo, 2010). However, a recent
randomised, double-blind, placebo-controlled clinical trial showed
that Hs tea (1.25 g of H. sabdariffa per 240 mL boiled water; 3 serv-
ings a day for 6 weeks) effectively reduced blood pressure in pre-
and mildly-hypertensive adults (McKay, Chen, Saltzman, &
Blumberg, 2010). Similar effects on decreasing systolic and dia-
stolic blood pressures were observed in mildly hypertensive type
II diabetic individuals when taking green or hibiscus (sour) tea
for 4 weeks (three times a day, 2 h after each meal) (Mozaffari-
Khosravi et al., 2013). The authors also concluded that this might
be useful in preventing the progression to moderate or more severe
hypertension, potentially decreasing cases of cardiovascular dis-
ease. Furthermore, a recent comprehensive review on animal and
human studies on the effect of Hs in the treatment of hypertension
and hyperlipidemia concluded that Hs has great potential to reduce
risk factors associated with cardiovascular diseases and warrants
further studies (Hopkins, Lamm, Funk, & Ritenbaugh, 2013).
Anthocyanins, including delphinidin-3-O-sambubioside (hibi-
scin) and cyanidin-3-O-sambubioside (gossypicyanin), have been
identiﬁed as being responsible for ACE inhibition (Herrera-
Arellano et al., 2007; Ojeda et al., 2010).
6.20. Anti-anaemic activity
A preliminary study on the use of Hs decoctions as an alterna-
tive source of iron for the treatment of anaemia and some other
mineral deﬁciency diseases was conducted and showed that dry
fermented calyces of hibiscus exhibited a very low pH value which
enhanced mineral availability. Another reason for enhancing min-
eral (iron, zinc, calcium and magnesium) bioavailability is the high
concentration of ascorbic acid (Falade et al., 2005).The effect of cHs extract (200 to 1000 mg/kg body weight) on
some haematological parameters in rats was studied to determine
its medicinal usefulness in the treatment of anaemia. The study
suggested that at a comparatively high dose range of 200 to
400 mg/kg, the extract had a beneﬁcial effect on the red cells, but
this was not sustained at even higher doses (Adigun, Ogundipe,
Anetor, & Odetunde, 2006). Another study using a rat model of
infection with Trypanosoma congolense showed that the use of Hs
WE (equivalent to 9.61 mg/100 g/day of ascorbic acid for 3 weeks)
prevented the disease-induced anomalies with increase of serum
creatinine and urea levels. It was concluded that consumption of
the extract ameliorated the pathological changes in blood as well
as hepatic and renal structures of T. congolense-infected rats. The
observed effects might be due to the ascorbic acid component or
other antioxidants present, which presumably kept the free radical
load in infected rats low as well as preventing the disease-associ-
ated depletion in systemic antioxidants. Nevertheless, further
studies are needed to determine the long-term effects and the
mechanism of action before recommendations could be made
(Umar et al., 2009).6.21. Others
The clinical use of Hs was reported for conjunctivitis
(Fraunfelder, 2004).
A Hs ﬂower tea was shown to be a very efﬁcient oral negative
contrast agent for magnetic resonance cholangiopancreaticogra-
phy (MRCP) study in reduction of high intensity ﬂuid in the stom-
ach and duodenum. The authors suggested that this was natural,
safe, inexpensive and palatable for oral administration
(Varavithya et al., 2005).
The effect of WE of dried cHs was also assessed on intestinal
transit in experimental rats providing a potential use in the control
of diarrhoea, as there was a reduction in percentage transit point
indicating a reduction in intestinal motility and increased transit
time. At an appropriate dose it could therefore become a constipat-
ing agent (Owulade, Eghianruwa, & Daramola, 2004).
A study reported that crude polysaccharides from Hs ﬂowers
had a potent stimulator effect on keratinocytes proliferation with
an inﬂuence on the early differentiation behaviours of the cells.
Thus, polysaccharide-containing extracts from Hs could be used
for dermatological or cosmetic applications (Brunold et al., 2004).
Another unorthodox use proposed for Hs ﬂowers is as a pH indi-
cator for environmental protection. The ﬂowers of this plant con-
tain anthocyanine pigments. As these pigments change colour
depending on pH, they could work as a environmental indicator
replacing synthetic indicators, therefore being safer for the user’s
health, minimising chemical pollution and become more cost
effective (Soltan & Sirry, 2002).
Genome shufﬂing of Streptomyces sp. U121 was used to achieve
improvements on the production of hydroxycitric acid, an organic
acid present in Hs (Hida et al., 2007). This technique is of great
interest to the biotechnological production of this compound in
the food industry as a safe food additive. As previously reported,
hibiscus acid, the (+)-allo-hydroxycitric acid lactone, has been
demonstrated to have an inhibitory effect on pancreatic a-amylase
and intestinal a-glucosidase (Hansawasdi et al., 2000, 2001),
resulting in reduction of carbohydrate metabolism and blood insu-
lin levels.7. Safety
H. sabdariffa preparations, predominantly the infusion and
aqueous extracts, have a long standing traditional use both in food
and in medicine, and in general are considered to be safe. The
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assessment. The literature search for this review did not reveal any
case reports of adverse reactions following oral consumption of H.
sabdariffa preparations.
7.1. Toxicology
In a bioassay for screening plant extracts for their biological
activity, the lethal dose (LD50) of three different types of Hs extract
was assessed in the brine shrimp toxicity assay. Aqueous Hs extract
(i.e., infusion) produced an LD50 of 9.59 lg/ml, while for the dichlo-
romethane extract it was 24.51 lg/ml and 4.75 lg/ml for the eth-
anolic extract (Serrano, Ortega, & Villar, 1996). Given the very
limited value of the brine shrimp assay for complex mixtures like
plant extracts (Manilal, Sujith, Kiran, Selvin, & Shakir, 2009) and
the incomplete information on the mode of preparation of the
extracts, this work is mentioned here for completeness only.
The LD50 in mice (b.w. 30 g) was reported to be about 0.4–
0.6 ml on intraperitoneal administration of a 30% aqueous Hs
decoction (20 min in distilled water) (Sharaf, 1962). The same
authors observed a lowered blood pressure in dogs (b.w.: 7 kg)
with no side effects after administering (i.p.) 10 ml of a 10% solu-
tion of the Hs decotion.
According to a study of Onyenekwe and coauthors, no deaths
were observed in Albino mice after fourteen day’s administration
(i.p.) at doses of 1000–5000 mg/kg b.w./d., thus the calculated
LD50 of cHs aqueous extract was >5000 mg/kg b.w. The same
authors assessed the effect of the extract on blood pressure in
spontaneously hypertensive and normotensive Wistar-Kyoto rats.
As part of this study it was observed that between the seventh
and the twenty-ﬁrst day after extract administration, the highest
dose of 1000 mg/kg resulted in spontaneous deaths in hyperten-
sive but not in normotensive rats. With reference to the well
known increased risk of sudden cardiac death in patients receiving
non-potassium sparing diuretics, the authors speculate that the
death of the animals may have been due to a diuretic effect of
the extract (Onyenekwe, Ajani, Ameh, & Gamaniel, 1999), however,
the dose found to be active is excessively high. Although Kirdpon
and co-authors report a decrease of potassium and sodium in 36
healthy young men after successive administration of 16 g/d Hibis-
cus ‘‘Juice’’ (while surprisingly no such effect was seen in the high
dose group with 24 g/d), this interpretation remains questionable
in view of a much larger and well-documented controlled clinical
study in which Hibiscus extract showed a natriuretic effect with
no effects on chloride, potassium and pH in 171 men with mild
to moderate hypertension (Herrera-Arellano, Flores-Romero,
Chávez-Soto, & Tortoriello, 2004). Lack of acute toxicity with calcu-
lated LD50 values >5000 mg/kg b.w. was reported for a methanolic
dried ﬂower extract in adult albino mice on a herb-drug interaction
study after 24 h administration (i.p.) (Ndu, Nworu, Ehiemere,
Ndukwe, & Ochiogu, 2011) and for an ethanolic extract of Hs seed
in albino Wistar rats while studying the effect of the extract on lac-
togenic activity (Gaya, Mohammad, Suleiman, Maje, & Adekunle,
2009).
Administration of the water-soluble fraction of a concentrated
cHs extract (extraction solvent: MeOH 80%) given orally at up to
15 successive doses of 250 mg/kg/d to Wistar albino rats showed
no pathological features in both liver and heart after 24 h
(Akindahunsi & Olaleye, 2003). The authors observed a dose-
related increase in the levels of serum aspartate aminotransferase
(AST) and alanine aminotransferase (ALT) when compared to the
control group. However, levels of the same enzymes decreased
slightly in the liver. In view of the extraordinarily high serum
AST value in the control group as compared to reference values
from the literature (Boehm et al., 2007), the conclusions of theauthors regarding a putative cardio- or liver toxicity of the tested
extract have to be read with caution.
In recent years the effect of Hibiscus extracts on reproduction
and development in rats has been subject to in vivo studies by sev-
eral authors. In female rats, addition of hibiscus extracts to drink-
ing water resulted in a dose-dependent reduction of ﬂuid and feed
intake. The effects observed in the pups included increased weight
gain and delayed onset of puberty. As the authors rightly state,
these effects have likely been caused by the reduced ﬂuid and feed
intake in accordance with earlier publications. Rather than repre-
senting speciﬁc toxicologic properties of hibiscus, the decreased
ﬂuid and feed intake and subsequent adverse effects observed in
this study may be the result of the animals dislike for the ﬂavour
of hibiscus (Iyare & Adegoke, 2008a,b; Iyare et al., 2010). Despite
the fact that earlier studies showed the LD50 to be above
5000 mg/kg and doses as high as 4600 mg/kg were administered
to rats in drinking water for 12 weeks with no increase in mortal-
ity, the extract induced testicular toxicity (reduced sperm counts
and spermatogenesis with evidence of marked degenerative histo-
logical changes) at all concentrations tested (1150–4600 mg/kg)
(Orisakwe, Husaini, & Afonne, 2004). Additionally, deleterious
effects on the testis and spermatozoa and an adverse inﬂuence in
the male reproductive fertility of albino mice were also reported
after a cHs WE was administered daily for 4 weeks in a dose of
200 mg/kg (Y. I. Mahmoud, 2012). In contrast to these studies, long
term administration of Hs WE for 10 weeks and hibiscus anthocy-
anins (50–200 mg/kg b.w.) for 5 days did not affect the male repro-
ductive system in rats (Ali et al., 2012).
Fakeye and co-authors assessed toxicological effects of a 90-
day oral administration of aqueous, ethanol or 50% ethanol
extracts of dried cHs at doses of 300 and 2000 mg/kg b.w., respec-
tively, in male Charles Foster rats. Strikingly contrasting with pre-
vious studies by various other authors, they observed a strong
toxicity with total mortality in all 2000 mg groups until day 28,
and in the aqueous and 50% ethanol groups at 300 mg, until
day 60 and 40, respectively. (Fakeye, Pal, Bawankule, Yadav, &
Khanuja, 2009). At a dose of 300 mg/kg (b.w.) all extract types
produced a signiﬁcant increase of plasma creatinine after 30 days
administration of the extracts. High creatinine blood levels may
be associated with muscular dystrophy, loss of kidney function
or even mortality. However, since the ethanol extract produced
the strongest increase in creatinine but no mortality at the
300 mg dose level, it is unlikely that the elevated creatinine levels
have been the cause of death in the other groups (Fakeye, Pal,
Bawankule, Yadav, & Khanuja, 2009). Overall, the results of this
study remain highly questionable. The possible reasons consid-
ered by the authors, including differences in anthocyanin content,
are not convincing in view of the still moderate anthocyanin
doses provided with the extracts.
A similar effect was observed on rat testis in a cisplatin (CIS)-
induced rodent model of reproductive toxicity when ethanol
extracts of Hs was administered for 26 days (1 g/kg per day)
(Amin & Hamza, 2006). The extract also revealed anti-mutagenic
activity in vitro against 1-nitropyrene, a potent mutagen (Olvera-
Garcia et al., 2008) and reduction of micronuclei in polychromatic
erythrocytes (PCEs) (Adetutu, Odunola, Owoade, Adeleke, &
Amuda, 2004). The administration of ethanolic Hs extracts
(200 mg/kg and 300 mg/kg, orally) in rabbits over a period of eight
weeks did not show any toxic effect when dyslipidemia and oxi-
dant stress associated with prolonged excessive intake of choles-
terol was studied in these animals (Ekor et al., 2010).
Based on the data presented above, dosages up to 200 mg/kg
should be safe and not show signs of toxicity, but further studies,
most importantly with chemically well characterised extracts,
are warranted.
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While there is no particular ground for suspicion of a relevant
interaction potential of Hibiscus, several preclinical and one clini-
cal study have addressed this issue. The sub-acute effect of an
aqueous cHs extract on CYP450 activity, clinical blood chemistry
and haematology was investigated in male Wistar rats at 250
and 1000 mg/kg/day for 30 days. The authors found no effect on
hepatic phase I enzymes (CYP 1A1, 1A2, 2B1/2, 2E1 and 3A) and
the extract did not signiﬁcantly affect blood chemistry and
haematology. (Prommetta, Phivthong-ngam, Chaichantipyuth,
Niwattisaiwong, & Lawanpraset, 2006). More recently, the interac-
tion of a methanolic Hs ﬂower extract and hydrochlorothiazide (a
diuretic drug) was examined in adult albino mice, albino rats
and healthy adult rabbits. Co-administration of the extract (20–
40 mg/kg b.w.) with hydrochlorothiazide (10 mg/kg) caused a
signiﬁcant increase in the volume of urine excreted, as well as a
signiﬁcant decrease in the pH of urine and the concentrations of
sodium, bicarbonate and chloride ions. It also increased and pro-
longed the plasma concentration, the mean area under the concen-
tration–time curve and the volume of distribution of the diuretic
drug over a 24 h sampling period (Ndu, Nworu, Ehiemere,
Ndukwe, & Ochiogu, 2011). Regarding the type of preparation
(methanol extract) and mode of administration (intraperitoneal),
the relevance of these ﬁndings for the use of traditional hibiscus
preparations remains highly questionable.
The pharmacokinetics of chloroquine (600 mg) and a freshly
prepared Hs beverage, similar in taste and concentration to the
one usually consumed by Sudanese people, were studied in healthy
males. The study showed a statistically signiﬁcant reduction in the
area under the plasma concentration versus time curve and the
peak plasma concentration of chloroquine (Mahmoud, Ali,
Homeida, & Bennett, 1994). In view of the very small group size
(N = 6) and the poor information on the mode of preparation and
dosage of the hibiscus beverage, the results of this study need to
be interpreted with caution.
The effect of so-called Zobo Drink (sweetened aqueous extract
prepared from 30 g dried hibiscus calyces/l) on acetaminophen
pharmacokinetics was studied in healthy young men (N = 6, cross-
over design). No signiﬁcant kinetic changes were observed when
the extract was administered concomitantly with acetaminophen,
except for a slight elevation of the clearance by ca. 11%. Given the
poorly described study protocol and the small sample size of N = 6,
the conclusions of the authors on a possible interaction potential of
hibiscus should be read with caution (Kolawole & Maduenyi,
2004).
Taken together, the data available today from preclinical and
clinical studies does not provide substantiated evidence of any
therapeutically relevant interaction potential of commonplace teas
or beverages containing hibiscus and its preparations. This comple-
ments the evidence based on the complete absence of drug inter-
action case reports involving hibiscus in the scientiﬁc literature.8. Scientiﬁc applications and translational research
In order to assess the level of translational research on Hs prod-
ucts, a patent research at the Espacenet patent database of the
European Patent Ofﬁce (http://worldwide.espacenet.com) incorpo-
rating 90+ national patent databases was performed in March 2013
(Worldwide – collection of published applications from 90+ coun-
tries). The result of this research on intellectual property rights
regarding Hs shows an increasing interest in novel technological
applications of potential future products derived from Hs.
Research queries used were: hibiscus (1450 hits) AND sabda-
riffa (51 hits) and common names for hibiscus or hibiscus tea(305 hits), like roselle (753 hits), karkade (22 hits), which delivered
a remarkable number of relevant hits, whereas results for the
terms rosemallow, ﬂor de Jamaica, Abelmoschus cruneatus, sorrel
(not Rumex acetosa) or bissap were not found or lead to non-rele-
vant patents.
Based on the research outcome, further queries were performed
with AND (Boolean operator) search options Tea, Extract, Food,
Health, Medic⁄ (for Medical, medicine/s, medicinal, medication/s
etc.). Table 2 shows a survey of the results/hits and representative
examples as selected patent titles, the nations of their application
(e.g. CN-China, JP-Japan, MX-Mexico etc.) and the year of their
publication.
Also recent clinical research topics are already reﬂected in
newer patents. For instance, the hypertensive effect of hibiscus
preparations, like the tea or extract can be found. The term ‘‘Hibis-
cus Tea’’ yielded in 305 hits and the query ‘‘Hibiscus Tea Hyperten-
sion’’, as well as, ‘‘Hibiscus AND Hypertension’’ yielded two
relevant patents. The same patents are found starting from ‘‘hibis-
cus extract’’ with 793 hits; those connected with AND hyperten-
sion showed two hits (see Table 3 for more details), whereas
AND ‘‘blood pressure’’ gave no hits. Regarding bioactive principles,
one of the main phytochemicals found in Hs calyxes, besides the
more known anthocyanins, is hibiscus acid, a (2S,3R)-hibiscus type
enantiomer. Patent search for ‘‘hibiscus acid’’ revealed 9 patents.
The query ‘‘hydroxycitric acid AND hibiscus’’ yielded 2 results,
but only ﬁve of those results are relevant (see Table 3 for more
details).
8.1. Future research
The available information on H. sabdariffa shows a wide range of
traditional as well as potentially new health applications and
therapeutic targets associated with such uses. More robust,
randomised, controlled clinical trials would be desirable with
well-characterised Hs preparations to corroborate its beneﬁcial
effects in pre- and mildly-hypertensive patients. The same applies
for its diuretic effects.
Obesity is a growing problem affecting not only adults but also
children. The effectiveness of Hs extract for metabolic disorders
like type II diabetes should be investigated further, as previous
clinical studies have shown promising effects on hyperlipidemia
and hypertension, conditions strongly correlated with type II dia-
betes or metabolic syndrome (Hernandez-Perez & Herrera-
Arellano, 2011; Hopkins, Lamm, Funk, & Ritenbaugh, 2013). Given
the longstanding safe use of hibiscus preparations as food, it could
be of great help in the supportive treatment of these pathologies.
Other therapeutic uses could also be pursued. In a study with
Hibiscus asper Hook.f., a closely related species, the methanolic
extract of leaves showed neuroprotective activity against 6-
OHDA-induced toxicity, through its antioxidant and anti-apoptotic
activities in a Parkinson’s disease model. Further studies will be
needed to determine if an extract of Hs would have similar effects.
Parkinson’s disease is a progressive neurodegenerative disorder
with limited therapeutic options available (Hritcu et al., 2011).
Hibiscus rosa sinensis L. roots have been used in fertility regula-
tion, showing strong anti-implantation and uterotropic activity
(Kholkute & Udupa, 1976; Vasudeva & Sharma, 2008). This plant
forms an important constituent of several Ayurvedic contraceptive
preparations (Kamboj & Dhawan, 1982). Further research with
Hibiscus species including Hs may be warranting with regard to
gynaecologic applications.
Limited data is available that correlates the therapeutic uses of
Hs and the chemical proﬁle of the extracts being used. Most of the
studies reported in this review only identify the type of extract and
part of plant used, but do not quantify the compounds present in
the extract.
Table 2
Results/hits and representative examples as selected patent titles of Hibiscus sabdariffa L.
Hits Hibiscus sabdariffa (total of 51 hits
(Hibiscus 1459 hits))
Roselle (746 hits) Karkade (22 hits)
AND tea 3 hits: relevant only JPS6212767 (B) of
Mutsuo (see Table 3)
46 hits: 39xCN,3xJP,2xRU,2xTW; published 2000–
2012. Selected patent titles: Flower/fruit/natural
tea drink and preparation method, blood
nourishing and facial beautifying composition,
refreshing composition with low glycaemic index,
weight reducing tea, health protection herbal tea,
radiation-resistant functional tea beverage, liver-
nourishing tea, natural colourful total nutrient, tea
drink capable of removing toxin and beautifying,
wisdom brain enlightening drink, tea for beneﬁting
wisdom and awakening brain, natural tea for
nourishing entrails and reducing blood fat, blood
sugar and blood pressure, tea drink for promoting
mentality and building body, health-care tea and
its making method, quick dissolving roselle tea bag,
Roselle tea and method for producing the same, etc
19 hits: 14 RU patents all of inventors: Butina,
et al. published 2010–2012. Functional food
product with antitoxic radioprotective,
immunomodulating, hypoglycaemic, ergogenic,
hepato-protective, hypocholesteremic,
interseptum protective, hypolipidemic,
antioxidant, herophophylactic, hypotensive
properties, anti-inﬂammatory properties against
digestive tract diseases, others: sweet liqueur or
alcoholic beverage 2xRU//2xJP Dough improving
agent,//1xEP drink//1986–2011 RU, JP, GE
AND extract 31 hits: EU, US, mainly Asian: CN, KR, TW;
published 1981–2013. Selected patent
titles: Patents on extract use in for hepatic,
inﬂammatory, metabolic disorders,
related to lipase activity inhibitor, fat
metabolism improving composition, anti-
allergic effect, anti-aging, cosmetic use as
activators of aconitase and their use in
anti-ageing skin care, skin protecting
agent, hair care, active oxygen scavenger
cosmetic, as meat quality preservative due
to its antioxidant effect
19 hits: 10xCN, 4xJP, 2xMX, 1xTW, 1xRU, 1xUS,
published 1987–2012. Method for extracting
roselle calyx red pigment, refreshing composition
with low glycaemic index, nutritional healthy
beverage, fabric refreshing cabinet device, the
improvement of anthocyanin content from
extraction of the roselle calyx infusion, preparation
capable of defaecating, adjusting qi and blood,
improving internal secretion and preventing
senescence, method for producting roselle chewing
gum and the resultant product, production of
concentrated drink from Hibiscus and Roselle, etc
15 hits: 14 RU patents of Inventor: Butina E.A.
et al.; published 2010-2012. On functional food
product, 1xJP external use
AND food 8 hits: JP, RU, TW, MX; published 2003–
2012. Composition of Hibiscus sabdariffa L.
calyces for the manufacture of drugs, food
supplements, functional food and
sweeteners for beverage, cosmetic use,
and in atherosclerosis prevention
53 hits: 25xCN, 5US, 2xMX etc.; published 1997–
2012. Selected patent titles: Nutrient health care
product for reducing trioxypurine, rose oral liquid,
rose jam, composition and food for improving
metabolic syndrome, health protection herbal tea,
method of preparing healthy food, roselle red
pigment, baked food, multicolored hypoglycaemic
tea drink, roselle fast food, drink and food obtained
by using leaf of roselle, food biologically active
addition, microorganism reduction methods and
compositions for food cleaning, cleaning/sanitising
methods, compositions, and/or articles for fabric,
articles, methods for cleaning produce and edible
and edible animal protein, etc
15 hits: 14 RU patents of Inventor: Butina E.A.
et al.; published 2010–2012. On functional food
product. 1xJP dough improving agent.
AND health 2 hits: (1) JP2005333942; published 2005.
Fermented herb vinegar and method for
producing the same. (2) CN1404740,
published 2003. Eight-ingredients slim tea
and its making method
51 hits: 47xCN, 2xTW, 2xJP; published 1995-2012.
Selected patent titles: many of the roselle tea
patents; health protection herbal tea, method of
preparing healthy food, natural tea drink capable of
clearing away heat, roselle mooncake, roselle eight-
ﬂavour rice dumpling, method for cultivating
roselle, application of roselle for preparing health
product for promoting lead-eliminating effect,
process of making preserved vanilla-roselle calyx,
roselle notoginseng beverage, roselle calyx jam,
roselle series product, etc
0 hit
AND medic⁄ 13 hits: mainly of Asian origin; published
2003 and thereafter. Use of the Hibiscus
sabdariffa extract in the preparation of a
medicament; mainly in atherosclerosis
prevention or inhibition; mainly within
mixtures of 1–8 herbals
24 hits: 15xCN, 3xRU etc.; published 1998–2012;
Roselle solid beverage, species ‘‘Dirosavit’’ eliciting
general tonic effect, roselle calyx beverage, elixir
for gastroenteric tract disease treatment
normalizing metabolism and eliciting sedative
effect, arrangement for delivering liquid to medical
treatment point, nitric oxide donor compounds and
pharmaceutical compositions for pulmonary
hypertension and other indications, etc
8 hits: 8 RU patents of Inventor: Butina, et al.,
published 2010–2012. On functional food product
Abbreviations: CN-China, JP-Japan, RU-Russia, TW-Taiwan, MX-Mexico, KR-Korea, GE-Georgia, EP-Europe, WO-World.
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macologic effects for Hs in obesity and diabetic conditions. In rela-
tion to type II diabetes, the combined presence of nephroprotective
and a-amylase inhibiting properties deserves further attention.
Overall, Hs preparations, particularly Hs tea and aqueous
extracts can be considered to be safe.An increasing body of pharmacologic and clinical studies is pro-
viding promising perspectives for an interesting range of therapeu-
tic applications as well as potential health claims. However, this
review has also identiﬁed a wide range of problems associated
with the quality of many aspects of these studies, but most impor-
tantly the pharmacological or clinical approaches (or models) used
Table 3
Patents list that include Hibiscus sabdariffa L., Hibiscus acid and Hs Tea and hypertention
Patent or
application
number
Issue date Title Summary Inventor(s) Applicant/assignee
US 6127553 (A) Oct 3, 2000 Convenient method for large-scale
isolation of hibiscus acid
The invention relates to a process for the isolation of Hibiscus acid or (+)hydroxycitric
acid lactone (2S,3R-dihydroxy-1,2,3-propanetricarboxylic acid lactone) from the leaves of
Hibiscus furcatus, Hibiscus sabdariffa and Hibiscus cannabinus. Garcinia acid, one of the
optical isomers of hydroxycitric acid is a potentially interesting molecule and found
extensive application in the pharmacological as well as synthetic fronts.
Ibrahim Ibnusaud, Rani
Rajasekharan, Teena
Philip, Salini Thomas
Department of
Science
and Technology,
Government of
India
US 6849278 (B) Feb 1, 2005 Method to counter oxidation of LDL,
decrease triglyceride or cholesterol
and inhibit atherosclerosis using
Hibiscus sabdariffa extract
A method for countering oxidization of low density lipoproteins, reducing cholesterol or
triglyceride in plasma or inhibiting atherosclerosis comprising administering an effective
amount of a Hibiscus sabdariffa extract
Chau-Jong Wang Universal Biotech
Co., Ltd.
US 2008/
0095867 A1
April
24, 2008
Hydroxycitric acid compositions from
garcinia cambogia and hibiscus sp.,
methods of making, and therapeutic
uses of same
Herbal compositions that comprise one or more of extracts of hydroxycitric acid,
() HCA and (+) HCA, from Garcinia cambogia and Hibiscus sabdariffa, and anthocyanins
from Hibiscus sabdariffa; all constituent extracts at independently controlled
concentrations which optionally include second therapeutic agents and pharmaceutically
acceptable additives. Processes for the preparation of these herbal compositions, such
processes including steps of extracting hydroxycitric acids and anthocyanins from Garcinia
and Hibiscus species, reacting the hydroxycitric acid with IA and IIA group metals of
periodic table, isolating the metal salt of hydroxycitric acid and drying and optionally
mixing anthocyanins. Uses of the compositions that comprise extracts containing
hydroxycitric acids (positive and negative isomers) and anthocyanins
from Garcinia and Hibiscus species optionally along with secondary agents and
pharmaceutically acceptable additives to manufacture a medicament for multiple
therapeutic uses, as well as beverages and powdered beverage premixes, all of which
provide healthful beneﬁts, are also provided
Scott Alexander
Moffett
Renaissance Herbs,
Inc.
Hs Tea
JPS6212767 (B) March
20, 1987
Tea bag of Hibiscus sabdariffa L. and
its preparation
Purpose: To obtain the titled tea bag useful for a fancy drink, having effect of herb
medicine on diabetes, hypertension, malum cordis, etc., by adhering uniformly and ﬁrmly
a speciﬁc amount of stevia extract powder as a sweetener to dried ground pieces of
Hibiscus sabdariffa L., followed by packing. Constitution: Dried ground pieces of Hibiscus
sabdariffa L. is sprayed with 1–3 wt% aqueous solution or alcoholic solution of stevia
extract powder so that the powder is adhered to Hibiscus sabdariffa L. uniformly and ﬁrmly.
Water or alcohol is evaporated by a dryer, etc. to make water content of the prepared
product 10 wt% and it is packed in tea bags.; Hibiscus sabdariffa L. contains no caffeine, has
effect of herb medicine on diabets, hypertension, malum cordis, renopathy, respiratory
diseases, diuresis, reduction of cholesterol in the blood, etc. and exhibits bright ruby and
proper acidity. While stevia extract powder has sweetness about 100 times as much as
that of sugar. An amount of the latter per bag is preferably 0.02–0.04 g. EFFECT: Even
excess drinking is harmless
Satou Mutsuo Hounan Shiyokuhin
Kogyo KK
Hibiscus acid
US6703515 (B2) March
09, 2004
Novel chiral derivatives of hibiscus
acid bearing lactone ring moiety,
process for preparing the same and a
convenient method for the large-
scale isolation of hibiscus acid
(see title) Saud Ibrahim Ibnu [IN]
Gopinath Chitra [IN]
Dept Science and
Technology,
Technology Bhavan
US6489493 (B2) December
03, 2002
Novel acyclic chiral derivatives of
hibiscus acid and the process of
preparing the same
(see title) Saud Ibrahim Ibnu [IN],
Nair Rani Rajasekharan
Saud Ibrahim Ibnu,
Nair Rani
Rajasekharan
US6127553 (A) October 03,
2000
Convenient method for large-scale
isolation of hibiscus acid
(see above) Ibnusaud Ibrahim [IN],
Rajasekharan Rani [IN]
Dept Science & Tech
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I. Da-Costa-Rocha et al. / Food Chemistry 165 (2014) 424–443 439and a lack of linking these to a careful proﬁling of the extracts.
Therefore, a better chemical proﬁling of the extracts, as well as
its standardisation and the correlation between the chemical com-
ponents and the pharmacologic/therapeutic action will be essential
in future studies with this very promising traditional plant.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.foodchem.2014.
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